Afya (NASDAQ:AFYA) CEO Sells $12,168.00 in Stock

Afya Limited (NASDAQ:AFYA) CEO Virgilio Deloy Capobian Gibbon sold 800 shares of Afya stock in a transaction on Thursday, March 26th. The shares were sold at an average price of $15.21, for a total transaction of $12,168.00. Following the completion of the sale, the chief executive officer owned 153,748 shares in the company, valued at approximately $2,338,507.08. This trade represents a 0.52% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Virgilio Deloy Capobian Gibbon also recently made the following trade(s):

• On Wednesday, March 25th, Virgilio Deloy Capobian Gibbon sold 3,900 shares of Afya stock. The stock was sold at an average price of $15.18, for a total transaction of $59,202.00.

Afya Trading Up 1.2%

NASDAQ:AFYA opened at $14.92 on Tuesday. The company has a 50-day moving average price of $14.41 and a 200-day moving average price of $14.73. Afya Limited has a 12 month low of $13.00 and a 12 month high of $19.90. The company has a current ratio of 2.20, a quick ratio of 0.98 and a debt-to-equity ratio of 0.21. The stock has a market cap of $1.40 billion, a price-to-earnings ratio of 10.22, a P/E/G ratio of 0.66 and a beta of 0.52.

Afya (NASDAQ:AFYA) last announced its quarterly earnings results on Wednesday, March 11th. The company reported $0.41 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.36 by $0.05. Afya had a net margin of 20.31% and a return on equity of 18.77%. The company had revenue of $147.08 million for the quarter, compared to analysts’ expectations of $174.74 million. Equities analysts predict that Afya Limited will post 1.52 EPS for the current year.

Afya Announces Dividend

The company also recently announced an annual dividend, which will be paid on Monday, April 6th. Shareholders of record on Wednesday, March 25th will be issued a dividend of $0.656 per share. The ex-dividend date is Wednesday, March 25th. This represents a dividend yield of 433.0%. Afya’s dividend payout ratio is 45.21%.

Hedge Funds Weigh In On Afya

Several large investors have recently made changes to their positions in the business. Doma Perpetual Capital Management LLC boosted its position in shares of Afya by 50.6% in the 3rd quarter. Doma Perpetual Capital Management LLC now owns 891,639 shares of the company’s stock worth $13,910,000 after purchasing an additional 299,419 shares in the last quarter. SPX Gestao de Recursos Ltda bought a new position in Afya during the 3rd quarter valued at approximately $2,895,000. Swedbank AB increased its position in Afya by 170.3% during the 4th quarter. Swedbank AB now owns 189,200 shares of the company’s stock valued at $2,916,000 after buying an additional 119,200 shares in the last quarter. Jump Financial LLC purchased a new position in Afya during the second quarter valued at $731,000. Finally, Qube Research & Technologies Ltd bought a new stake in Afya in the third quarter worth $610,000. 88.02% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of research analysts have recently commented on the company. Wall Street Zen upgraded Afya from a “buy” rating to a “strong-buy” rating in a research note on Saturday, March 14th. Sanford C. Bernstein upgraded Afya to a “market perform” rating in a research report on Friday, January 16th. UBS Group reiterated a “neutral” rating and issued a $16.00 price objective (down from $18.00) on shares of Afya in a report on Friday, January 16th. JPMorgan Chase & Co. reissued a “neutral” rating and set a $22.00 price objective (down from $24.50) on shares of Afya in a research report on Wednesday, January 7th. Finally, Zacks Research upgraded shares of Afya from a “strong sell” rating to a “hold” rating in a report on Monday, March 9th. One analyst has rated the stock with a Buy rating and seven have issued a Hold rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of $17.30.

About Afya

Afya Ltd. operates as a leading provider of medical education and training services in Brazil. The company offers a comprehensive suite of educational programs that span undergraduate medical degrees, residency exam preparation, continuing medical education (CME) and digital learning platforms. Through a network of partner institutions and its own campus operations, Afya supports students at every stage of the medical training continuum, from enrollment in medical schools to ongoing professional development for practicing physicians.

At the core of Afya’s offerings is its undergraduate medical program, delivered through a combination of in-person courses at affiliated campuses and fully digital curricula.